James Samuel Shannon, Director at MannKind, holds 0.00 shares in Horizon Therapeutics (Ticker: HZNP), holds 12.74K shares in MannKind (Ticker: MNKD), holds 0.00 shares in Endocyte (Ticker: ECYT).

See the Hottest Stocks Based on Insider Trading >

James Samuel Shannon
MannKind (MNKD)
Director

Ranked #90,804 out of 98,743 Corporate Insiders

Profitable Transactions

0 out of 2 Profitable Transactions

Average Return

-87.70%

Average return per transaction

Time Frame

1 Year

Compare to

No Benchmark

How are Insiders Ranked?

Insider Holdings

100.00%

MNKD

A breakdown of James Samuel Shannon's holdings

See the Top Stocks by Insiders

Insider Roles

MannKind
(MNKD)

Director

Roles that James Samuel Shannon holds in companies

See the Top Corporate Insiders

Most Profitable Insider Trade

Stock:

Horizon Therapeutics
(HZNP)

Rating:Informative Sell

Date:Mar 03, 2021 - Mar 03, 2022

Return:-7.60%

The most profitable trade made by James Samuel Shannon

See the Latest Stocks Traded by Insiders

James Samuel Shannon's Trading History

MNKD

MannKind

Jun 02, 2015

Director

Uninformative Buy

―

$54.90K

HZNP

Horizon Therapeutics

Oct 06, 2023

―

Uninformative Sell

6.62M

$0.00

ECYT

Endocyte

―

$0.00

List of latest transactions for each holding click on a transaction to see James Samuel Shannon's performance on stock

See All Insider Trading from Today

James Samuel Shannon insider profile FAQ

What is the percentage of profitable transactions made by James Samuel Shannon?

The percentage of profitable transactions made by James Samuel Shannon is 0%.

What is the average return per transaction made by James Samuel Shannon?

The average return per transaction made by James Samuel Shannon is -87.70%.

What stocks does James Samuel Shannon hold?

James Samuel Shannon holds: MNKD, HZNP, ECYT stocks.

What was James Samuel Shannon’s latest transaction?

James Samuel Shannon latest transaction was an Uninformative Sell of $6.62M.

What was James Samuel Shannon's most profitable transaction?

James Samuel Shannon’s most profitable transaction was an Informative Sell of HZNP stock on March 3, 2021. The return on the trade was -7.60%.

What is James Samuel Shannon's role in MannKind?

James Samuel Shannon's role in MannKind is Director.

How can I follow the stock ratings of top corporate insiders?

Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.

James Samuel Shannon Insider Profile

James Samuel Shannon MannKind (MNKD)Director